Rua Life Sciences PLC (RUA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Rua Life Sciences PLC (RUA) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX29.00K ≈ $3.53 USD) by net assets (GBX7.23 Million ≈ $879.44 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Rua Life Sciences PLC for the company's overall valuation and market capitalisation.
Rua Life Sciences PLC - Cash Flow Conversion Efficiency Trend (1994–2025)
This chart illustrates how Rua Life Sciences PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Rua Life Sciences PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rua Life Sciences PLC ranked by their cash flow conversion efficiency. Explore Rua Life Sciences PLC earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kiromic Biopharma Inc
NASDAQ:KRBP
|
0.290x |
|
TRELLUS HEALTH LS -0006
F:85Q
|
N/A |
|
Gangotri Textiles Limited
NSE:GANGOTRI
|
0.000x |
|
UMT United Mobility Technology AG
XETRA:UMDK
|
-0.046x |
|
NAHL Group PLC
LSE:NAH
|
0.154x |
|
JDC Group AG
XETRA:JDC
|
0.053x |
|
TEVANO SYSTEMS HLDGS INC.
F:7RBA
|
N/A |
|
Mineral & Financial Investments Ltd
LSE:MAFL
|
0.012x |
Annual Cash Flow Conversion Efficiency for Rua Life Sciences PLC (1994–2025)
The table below shows the annual cash flow conversion efficiency of Rua Life Sciences PLC from 1994 to 2025. View current stock price of Rua Life Sciences PLC for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | GBX7.23 Million ≈ $879.44 |
GBX-137.00K ≈ $-16.67 |
-0.019x | +36.02% |
| 2025-03-31 | GBX7.39 Million ≈ $899.39 |
GBX-219.00K ≈ $-26.65 |
-0.030x | +83.98% |
| 2024-03-31 | GBX7.18 Million ≈ $873.84 |
GBX-1.33 Million ≈ $-161.58 |
-0.185x | +26.24% |
| 2023-03-31 | GBX4.68 Million ≈ $569.79 |
GBX-1.17 Million ≈ $-142.84 |
-0.251x | +30.09% |
| 2022-03-31 | GBX6.58 Million ≈ $801.08 |
GBX-2.36 Million ≈ $-287.27 |
-0.359x | -114.35% |
| 2021-03-31 | GBX8.51 Million ≈ $1.03K |
GBX-1.42 Million ≈ $-173.14 |
-0.167x | +11.70% |
| 2020-03-31 | GBX2.27 Million ≈ $276.80 |
GBX-431.00K ≈ $-52.44 |
-0.189x | -32.48% |
| 2019-03-31 | GBX3.00 Million ≈ $365.01 |
GBX-429.00K ≈ $-52.20 |
-0.143x | -141.87% |
| 2018-03-31 | GBX1.02 Million ≈ $123.62 |
GBX347.00K ≈ $42.22 |
0.342x | +325.07% |
| 2017-03-31 | GBX1.05 Million ≈ $127.99 |
GBX-159.62K ≈ $-19.42 |
-0.152x | -318.79% |
| 2016-03-31 | GBX1.22 Million ≈ $148.59 |
GBX84.70K ≈ $10.31 |
0.069x | +158.98% |
| 2015-03-31 | GBX1.61 Million ≈ $196.39 |
GBX-189.82K ≈ $-23.10 |
-0.118x | -708.78% |
| 2014-03-31 | GBX1.65 Million ≈ $200.81 |
GBX-24.00K ≈ $-2.92 |
-0.015x | -111.36% |
| 2013-03-31 | GBX2.71 Million ≈ $329.20 |
GBX346.19K ≈ $42.12 |
0.128x | +703.72% |
| 2012-03-31 | GBX3.18 Million ≈ $386.67 |
GBX50.59K ≈ $6.16 |
0.016x | +103.25% |
| 2011-03-31 | GBX3.12 Million ≈ $379.86 |
GBX-1.53 Million ≈ $-185.79 |
-0.489x | -29.15% |
| 2010-03-31 | GBX5.41 Million ≈ $658.61 |
GBX-2.05 Million ≈ $-249.43 |
-0.379x | -67.19% |
| 2009-03-31 | GBX6.13 Million ≈ $746.09 |
GBX-1.39 Million ≈ $-169.00 |
-0.227x | -41.48% |
| 2008-03-31 | GBX7.11 Million ≈ $865.57 |
GBX-1.14 Million ≈ $-138.58 |
-0.160x | +41.90% |
| 2007-03-31 | GBX2.96 Million ≈ $360.27 |
GBX-816.00K ≈ $-99.28 |
-0.276x | -9.29% |
| 2006-03-31 | GBX5.11 Million ≈ $621.50 |
GBX-1.29 Million ≈ $-156.71 |
-0.252x | +32.73% |
| 2005-03-31 | GBX5.65 Million ≈ $687.81 |
GBX-2.12 Million ≈ $-257.82 |
-0.375x | -192.12% |
| 2004-03-31 | GBX7.57 Million ≈ $920.69 |
GBX-971.00K ≈ $-118.14 |
-0.128x | +92.57% |
| 2003-03-31 | GBX6.91 Million ≈ $840.50 |
GBX-11.93 Million ≈ $-1.45K |
-1.727x | -514.49% |
| 2002-03-31 | GBX46.21 Million ≈ $5.62K |
GBX-12.99 Million ≈ $-1.58K |
-0.281x | -135.96% |
| 2001-03-31 | GBX35.96 Million ≈ $4.38K |
GBX-4.28 Million ≈ $-521.24 |
-0.119x | -144.44% |
| 2000-03-31 | GBX41.55 Million ≈ $5.06K |
GBX-2.02 Million ≈ $-246.38 |
-0.049x | +86.06% |
| 1999-03-31 | GBX4.11 Million ≈ $499.95 |
GBX-1.44 Million ≈ $-174.72 |
-0.349x | +35.64% |
| 1998-03-31 | GBX2.52 Million ≈ $306.98 |
GBX-1.37 Million ≈ $-166.69 |
-0.543x | -77.10% |
| 1997-03-31 | GBX3.12 Million ≈ $379.37 |
GBX-956.00K ≈ $-116.32 |
-0.307x | -146.61% |
| 1996-03-31 | GBX678.00K ≈ $82.49 |
GBX446.00K ≈ $54.27 |
0.658x | +112.42% |
| 1995-03-31 | GBX44.00K ≈ $5.35 |
GBX-233.00K ≈ $-28.35 |
-5.295x | -4754.17% |
| 1994-03-31 | GBX330.00K ≈ $40.15 |
GBX-36.00K ≈ $-4.38 |
-0.109x | -- |
About Rua Life Sciences PLC
RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast… Read more